National Headlines

Will ‘Netflix’ model fix drug prices?

Scott Gottlieb

Scott Gottlieb | Resident Fellow, American Enterprise Institute

 

Scott Gottlieb via Twitter: My op ed article for @CNBC today, ahead of their HealthyReturns Conference tomorrow. As cures are developed for many inherited and debilitating diseases that can exacerbate poverty; we cannot let access to these new treatments become a divide that further separates the better off from the poor.

RELATED STORY

(LISTEN) EP. 31 | The DOCPRENEUR PODCAST: “Membership” Pharmacy. Where Everyone Qualifies + Rx Is Affordable

Above: The 2019 Concierge Medicine FORUM returns to ATLANTA, GA USA, October 25-26, 2019. The two day national gathering of high-level Concierge Medicine Physiciains and healthcare leadership features presentations on: Legal/Regulatory; Different Business Models Used Today and Why; Genomics; Hospital-based Concierge Care Programs; A.I.; EHR; Pharmacogenomics Education and more. LEARN MORE & Register to Attend — https://conciergemedicineforum.com/

Former Food and Drug Administration Commissioner Scott Gottlieb argued that new treatments should be available to everyone, not just the wealthy. “Drugmakers need to make sure there’s equitable access to effective therapies,” he wrote in a commentary published by CNBC. He also argued that drugmakers should negotiate with states on “Netflix-style” subscription models similar to Louisiana’s contract with Gilead Sciences, which plans to treat the state’s Medicaid population with its hepatitis-C drugs in exchange for promised volume of a certain number of patients.

READ MORE …

SOURCE: https://www.cnbc.com/2019/05/20/commentary-new-drug-cures-risk-widening-income-gap-for-the-poor.html

Categories: National Headlines